Published in Gene Therapy Weekly, August 25th, 2005
The system improves the molecular weight determination of larger synthetic oligonucleotides (>50 bases) as well as synthetic peptides. Novatia specializes in developing an integrated system encompassing hardware, software, method development and automated data analysis.
Traditionally, larger synthetic oligonucleotides are analyzed by capillary electrophoresis and by PAGE analysis. When molecular weight information is needed, MALDI-TOF mass analysis is...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.